TY - JOUR
T1 - HIV-1 infection in persons homozygous for CCR5-Δ32 allele
T2 - The next case and the review
AU - CASCADE Collaboration in EuroCoord
AU - Smoleń-Dzirba, Joanna
AU - Rosińska, Magdalena
AU - Janiec, Janusz
AU - Beniowski, Marek
AU - Cycoń, Mariusz
AU - Bratosiewicz-Wąsik, Jolanta
AU - Wasik, Tomasz J.
AU - Kelleher, Tony
AU - Cooper, David
AU - Grey, Pat
AU - Finlayson, Robert
AU - Bloch, Mark
AU - Ramacciotti, Tim
AU - Gelgor, Linda
AU - Smith, Don
AU - Zangerle, Robert
AU - Gill, John
AU - Lutsar, Irja
AU - Chêne, Geneviève
AU - Dabis, Francois
AU - Thiebaut, Rodolphe
AU - Masquelier, Bernard
AU - Costagliola, Dominique
AU - Guiguet, Marguerite
AU - Vanhems, Philippe
AU - Chaix, Marie Laure
AU - Ghosn, Jade
AU - Meyer, Laurence
AU - Boufassa, Faroudy
AU - Hamouda, Osamah
AU - Kücherer, Claudia
AU - Bartmeyer, Barbara
AU - Antoniadou, Anastasia
AU - Chrysos, Georgios
AU - Daikos, Georgios L.
AU - Touloumi, Giota
AU - Pantazis, Nikos
AU - Katsarou, Olga
AU - Rezza, Giovanni
AU - Dorrucci, Maria
AU - Monforte, Antonella d’Arminio
AU - De Luca, Andrea
AU - Prins, Maria
AU - Geskus, Ronald
AU - van der Helm, Jannie
AU - Schuitemaker, Hanneke
AU - Sannes, Mette
AU - Brubakk, Oddbjorn
AU - Murphy, Gary
AU - Fenton, Kevin
N1 - Publisher Copyright:
© 2017, Publicaciones Permanyer. All rights reserved.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - CC-chemokine receptor 5 serves as the coreceptor for the HIV-1 R5 strains, which are responsible for the majority of HIV transmissions. A deletion of 32 nucleotides in the gene encoding this receptor (termed CCR5-Δ32) leads to the suppression of CC-chemokine receptor 5 presentation at the cell surface, thus impeding process of HIV entry into the cell. Individuals homozygous for the CCR5-Δ32 allele are resistant to infection with HIV-1 R5 strains, and are extremely rare among HIV-1-infected individuals. We have described a person homozygous for CCR5-Δ32, who was infected with subtype B HIV-1. Based on examination of proviral V3 sequences obtained from the first clinical blood sample within less than five months after seroconversion, the CXC-chemokine receptor 4-using strains (X4 or R5/X4) were detected. Data on HIV-1-infected patients homozygous for the CCR5-Δ32 allele, course of HIV-1 infection in these cases, and the infecting viral strains from current and all former reports on HIV-1 infection in CCR5-Δ32 homozygotes were gathered and compared. Identification of HIV-1-infected persons homozygous for CCR5-Δ32 supports the evidence that the lack of functional CC-chemokine receptor 5 at the cell surface does not confer absolute protection against HIV-1 infection, which should be considered when designing future HIV pre-exposure prophylaxis schemes based on CC-chemokine receptor 5 blocking drugs.
AB - CC-chemokine receptor 5 serves as the coreceptor for the HIV-1 R5 strains, which are responsible for the majority of HIV transmissions. A deletion of 32 nucleotides in the gene encoding this receptor (termed CCR5-Δ32) leads to the suppression of CC-chemokine receptor 5 presentation at the cell surface, thus impeding process of HIV entry into the cell. Individuals homozygous for the CCR5-Δ32 allele are resistant to infection with HIV-1 R5 strains, and are extremely rare among HIV-1-infected individuals. We have described a person homozygous for CCR5-Δ32, who was infected with subtype B HIV-1. Based on examination of proviral V3 sequences obtained from the first clinical blood sample within less than five months after seroconversion, the CXC-chemokine receptor 4-using strains (X4 or R5/X4) were detected. Data on HIV-1-infected patients homozygous for the CCR5-Δ32 allele, course of HIV-1 infection in these cases, and the infecting viral strains from current and all former reports on HIV-1 infection in CCR5-Δ32 homozygotes were gathered and compared. Identification of HIV-1-infected persons homozygous for CCR5-Δ32 supports the evidence that the lack of functional CC-chemokine receptor 5 at the cell surface does not confer absolute protection against HIV-1 infection, which should be considered when designing future HIV pre-exposure prophylaxis schemes based on CC-chemokine receptor 5 blocking drugs.
KW - CCR5 blocker
KW - Coreceptor
KW - HIV-1 transmission
KW - Homozygous CCR5-Δ32 mutation
UR - http://www.scopus.com/inward/record.url?scp=85039697586&partnerID=8YFLogxK
M3 - Review article
C2 - 28534889
AN - SCOPUS:85039697586
SN - 1139-6121
VL - 19
SP - 219
EP - 230
JO - AIDS Reviews
JF - AIDS Reviews
IS - 4
ER -